Director​/ Senior Director ​/ Executive Director – Translational PKPD Project Leader

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life‑changing medicines, strengthen how health is understood and managed, and support the communities we serve.

This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Eli Lilly and Company is committed to using its innovation‑based strategy to discover, develop and deliver innovative medicines that help improve the lives of people. In support of this goal, the Pharmacokinetics/ Pharmacodynamics and Pharmacometrics, (PMx) organization provides leadership and technical expertise to support the discovery and development of new medicines from preclinical lead molecule identification to clinical post‑drug approval, with the goal of identifying and developing the right drug with the right dose for the right patient using model‑informed drug research and development (MIDD) approaches.

To further advance the science in this field, we are seeking a scientific director who is experienced in mechanistic PK, PK/PD, and/or PBPK modeling of novel modalities.

We are passionate about making an impact in the lives of our patients, developing people to their full potential, and pushing the boundaries of science. Consider joining Team Lilly to contribute to Lilly’s drug discovery and development efforts.

• Serve as the Discovery PKPD project leader for genetic medicines programs, including ASOs, siRNA, LNP‑mediated delivery, gene therapy (AAV and non‑viral vectors), and antibody‑siRNA conjugates (ARC).
• Develop and implement modeling strategies that enhance decision‑making for genetic medicines inform translational research strategies.
• Design, analyze, and interpret quantitative pharmacology and PK/PD studies.
• Collaborate effectively with scientists within and outside the functional area to integrate PK/PD into team strategy and contribute to project team discussions, guiding key go/no‑go decisions with quantitative approaches.
• Communicate quantitative findings both internally and externally through scientific publications, conference presentations, and cross‑functional forums.
• Mentor junior scientists and contribute to the growth of PKPD modeling capabilities within the genetic medicines space and neuroscience space.

• PhD in Pharmacokinetics/Pharmacodynamics, Pharmacology, Pharmaceutical Sciences, Biomedical engineering, or a related subject area with experience applying quantitative approaches, with at 5 or more years of relevant industry or CRO experience in translational and/or mechanistic PKPD modeling.
• Experience with empirical or mechanistic PK/PD modeling to support drug discovery and/or development.
• Experience with DMPK and translational PK/PD modeling to support interspecies scaling, human dose projections, and first‑in‑human study design.
• Experience with computational modeling and simulation software such as NONMEM, mrgsolve, MATLAB, Monolix, SimCYP, PKSim, or equivalent platforms.
• Experience working effectively in a cross‑functional, matrixed collaborative environment.

• Previous people management experience is preferred, though this may include management in a matrix environment.
• Experience with PKPD or PBPK modeling applied to oligonucleotide therapeutics (ASO, siRNA), LNP delivery platforms, gene therapy (AAV or non‑viral), and/or antibody‑siRNA conjugates (ARCs).
• Understanding of the outstanding disposition, intracellular delivery, tissue distribution, and Pharmacodynamics and durability of nucleic acid‑based therapeutics.
• Excellent self‑management, organizational skills, and ability to manage multiple programs simultaneously.
• Publication record in peer‑reviewed journals in quantitative pharmacology, genetic medicines, or related fields.
• Make a purposeful impact with real…